1. Wu CS, Tsai YT, Tsai HJ (2015) Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study. J Am Heart Assoc 4:e001568
2. Onrust SV, McClellan K (2001) Perospirone. CNS Drugs 15:329–337
3. Deeks ED, Keating GM (2010) Blonanserin: a review of its use in the management of schizophrenia. CNS Drugs 24:65–84
4. Sumitomo Dainippon Pharma Co., Ltd. Blonanserin: Lonasen tablets 2 mg/Lonasen tablets 4 mg/Lonasen powder 2% common technical document 2.6.2 [In japanese] Available at:
http://www.pmda.go.jp/drugs/2008/P200800002/index.html
Accessed on March 5th, 2019
5. Suzuki K, Kanaji Y, Kida N, Takagi T, Inamura Y, Suzuki A, Kurihara K, Ono Y, Shimizu S, Otomo K, Isobe M (2011) A case of myotonic dystrophy who developed QT prolongation and torsade de pointes. Shinzo 43:65–72 (in Japanese)